Medtronic Lawsuit

Medtronic announced plans today to buy a majority interest in a Chinese medical device company.
The deal, which gives Medtronic a 51% interest, involves the company Shandong Weigao Group Medical Polymer Co., Ltd. It is reported to cost roughly $220 million.
Once the deal is complete, Medtronic and Shandong will jointly market spinal, orthopedic, and trauma devices […]

[Read more →]

Medtronic’s new version of leads for the Quattro defibrillator have been approved for sale in Japan. These are now the only leads available in Japan made by Medtronic since the recall of the Fidelis leads in October.
The new leads contain steroids which they release into the arteries to reduce inflammation.
In October, Medtronic recalled their other […]

[Read more →]

Since Medtronic recalled their leads in October, roughly a quarter of a million people have wondered whether the lead meant to save their life will fail or accomplish its purpose. The most common debate is whether or not they should replace the leads and defibrillators or not. This decision is meant to erase doubt of […]

[Read more →]

The Wall Street Journal reports that Medtronic, Inc. continues to be under federal investigation for alleged payments made to doctors. The Senate Finance Committee, the SEC and the U.S. attorney’s office for Eastern Division of Pennsylvania have all requested some sort of documentation from Medtronic. In September 2007, the SEC began an informal investigation trying […]

[Read more →]

The Star Tribune reports that on Tuesday, December 4, 2007, Medtronic claims in their quarterly filing that the U.S. attorney’s office for the Eastern District of Pennsylvania sent them a letter requesting documents relating to the Fridley company’s relationship with an unnamed customer. The U.S. attorney’s office also requested information on “payments or things of […]

[Read more →]